PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24596595-1	2014	Genome-wide association studies (GWAS) have identified common polymorphisms in or near GC, CYP2R1, CYP24A1, and NADSYN1/DHCR7 genes to be associated with circulating levels of 25-hydroxyvitamin D [25(OH)D] in European populations.	25-hydroxyvitamin D	176-195	7-dehydrocholesterol reductase	Homo sapiens	120-125	
23734184-3	2013	METHODOLOGY/PRINCIPAL FINDINGS: Associations between CYP2R1, GC, and DHCR7 genotypes that are determinants of reduced 25-hydroxyvitamin D (25[OH]D3) serum levels and the risk of HCV-related HCC development were investigated for 1279 chronic hepatitis C patients with HCC and 4325 without HCC, respectively.	25-hydroxyvitamin D	118-137	7-dehydrocholesterol reductase	Homo sapiens	69-74	
24642724-0	2013	Effect of polymorphisms in the NADSYN1/DHCR7 locus (rs12785878 and rs1790349) on plasma 25-hydroxyvitamin D levels and coronary artery disease incidence.	25-hydroxyvitamin D	88-107	7-dehydrocholesterol reductase	Homo sapiens	39-44	
24642724-1	2013	BACKGROUND/AIMS: Recent genome-wide association studies have identified the rs1790349 and rs12785878 single-nucleotide polymorphisms (SNPs), present in the NADSYN1/DHCR7 locus, as an influential player on circulating 25-hydroxyvitamin D [25(OH)D] levels, which itself has been linked to various diseases including cardiovascular disease (CVD).	25-hydroxyvitamin D	217-236	7-dehydrocholesterol reductase	Homo sapiens	164-169	
25406188-8	2014	Each increase in DHCR7/CYP2R1 allele score was associated with a 1.9 nmol/L lower plasma 25-hydroxyvitamin D concentration and with increased all cause, cancer, and other mortality but not with cardiovascular mortality.	25-hydroxyvitamin D	89-108	7-dehydrocholesterol reductase	Homo sapiens	17-22	
22576297-1	2012	UNLABELLED: Recently, genome-wide studies identified genetic variants that affect serum 25-hydroxyvitamin D levels in healthy populations (rs12785878, near dehydrocholesterol reductase, DHCR7; rs10741657, at CYP2R1; and rs7041, at vitamin D binding protein, GC).	25-hydroxyvitamin D	88-107	7-dehydrocholesterol reductase	Homo sapiens	186-191	
21972121-1	2012	Recent studies have identified common variants in or near GC, CYP2R1 and NADSYN1/DHCR7 to be associated with 25-hydroxyvitamin D [25(OH)D] levels in European populations.	25-hydroxyvitamin D	109-128	7-dehydrocholesterol reductase	Homo sapiens	81-86	
29343764-2	2018	Previous GWAS of serum 25-hydroxyvitamin D concentrations have identified four genome-wide significant loci (GC, NADSYN1/DHCR7, CYP2R1, CYP24A1).	25-hydroxyvitamin D	23-42	7-dehydrocholesterol reductase	Homo sapiens	121-126	
24663808-0	2014	A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness).	25-hydroxyvitamin D	8-27	7-dehydrocholesterol reductase	Homo sapiens	72-77